Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C3TI
|
||||
Former ID |
DIB014522
|
||||
Drug Name |
Resimmune
|
||||
Synonyms |
A-dmDT390-bisFv immunotoxin
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 1/2 | [549482] | ||
Company |
Angimmune
|
||||
Target and Pathway | |||||
Target(s) | T-cell surface glycoprotein CD3 epsilon chain | Target Info | Modulator | ||
NetPath Pathway | TCR Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
PANTHER Pathway | T cell activation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.